Aptamers and Small Molecules Play Tug of War

Recently, aptamers began to emerge as therapeutics. In this issue of Chemistry & Biology, Famulok and colleagues present a twist on this concept, using an enzyme-inhibiting aptamer as a tool to screen for small molecules that block HIV replication.